Gilead Sciences will continue to benefit from the success of its new hepatitis C drugs. Although GILD's stock has significantly outperformed the market since the beginning of 2012, it still has room to move up. Gilead Sciences has …
Owning a stock that doubles in value in less than 11 months is exciting. But what word do you use for a stock that rises to 4.5 times its original price in that amount of time? Thrilling? Exhilarating? Whatever word is the best fit, it applies to …
There haven't been too many stocks hotter than Exact Sciences (NASDAQ: EXAS) over the past couple of years. The molecular diagnostics company enjoyed a fantastic 2017. Since 2016, Exact Sciences' share price has soared more …
Every day, Wall Street analysts upgrade some stocks, downgrade others, and "initiate coverage" on a few more. But do these analysts even know what they're talking about? Today, we're taking one high-profile Wall Street pick and putting it …
Gilead Sciences has been a dream stock for long-term investors. Anyone who was smart enough to get in at the IPO in 1992 and hold the stock until today are sitting on a gain of around 17,000%! That kind of performance is simply …
Investors in Axovant Sciences Ltd. AXON need to pay close attention to the stock based on moves in the options market lately. That is because the Jan 19 th 2018 $15.00 Call had some of the highest implied volatility of all equity options …
Nasdaq1mon
With nothing more than a quick view of its chart and a passing glance at the headlines, it would be easy to decide Gilead Sciences, Inc. (NASDAQ:GILD) is best left avoided. The GILD stock price took a fairly big tumble after the release of …